Recently a novel coronavirus (2019-nCoV) has emerged from Wuhan, China, 26 causing symptoms in humans similar to those caused by SARS coronavirus CoV). Since SARS-CoV outbreak in 2002, extensive structural analyses have revealed 28 key atomic-level interactions between SARS-CoV spike protein receptor-binding domain 29 (RBD) and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate 30 both the cross-species and human-to-human transmissions of SARS-CoV. Here we 31 analyzed the potential receptor usage by 2019-nCoV, based on the rich knowledge about 32 SARS-CoV and the newly released sequence of 2019-nCoV. First, the sequence of 2019-33 nCoV RBD, including its receptor-binding motif (RBM) that directly contacts ACE2, is 34 similar to that of SARS-CoV, strongly suggesting that 2019-nCoV uses ACE2 as its 35 receptor. Second, several critical residues in 2019-nCoV RBM (particularly Gln493) 36 provide favorable interactions with human ACE2, consistent with 2019-nCoV's capacity 37 for human cell infection. Third, several other critical residues in 2019-nCoV RBM 38 (particularly Asn501) are compatible with, but not ideal for, binding human ACE2, 39 suggesting that 2019-nCoV has acquired some capacity for human-to-human 40 transmission. Last, while phylogenetic analysis indicates a bat origin of 2019-nCoV, 41 2019-nCoV also potentially recognizes ACE2 from a diversity of animal species (except 42 mice and rats), implicating these animal species as possible intermediate hosts or animal 43 models for 2019-nCoV infections. These analyses provide insights into the receptor 44 usage, cell entry, host cell infectivity and animal origin of 2019-nCoV, and may help 45 epidemic surveillance and preventive measures against 2019-nCoV. 46 47 on February 13, 2020 by guest http://jvi.asm.org/ Downloaded from Significance 48 The recent emergence of Wuhan coronavirus (2019-nCoV) puts the world on 49 alert. 2019-nCoV is reminiscent of the SARS-CoV outbreak in 2002-2003. Our decade-50 long structural studies on the receptor recognition by SARS-CoV have identified key 51 interactions between SARS-CoV spike protein and its host receptor angiotensin-52 converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-53 human transmissions of SARS-CoV. One of the goals of SARS-CoV research was to 54 build an atomic-level iterative framework of virus-receptor interactions to facilitate 55 epidemic surveillance, predict species-specific receptor usage, and identify potential 56 animal hosts and animal models of viruses. Based on the sequence of 2019-nCoV spike 57 protein, we apply this predictive framework to provide novel insights into the receptor 58 usage and likely host range of 2019-nCoV. This study provides a robust test of this 59 reiterative framework, providing the basic, translational and public health research 60 communities with predictive insights that may help study and battle this novel 2019-61 nCoV. 62 63 on February 13, 2020 by guest
infections and about 800 deaths (1) (2) (3) (4) . It briefly re-emerged in 2003-2004, with 4 72 confirmed cases of mild human infections and no human-to-human transmission (5-7). 73
SARS-CoV has also been isolated from animals and been adapted to lab cell culture (5, 74 8-11) . It is believed that bats and palm civets were the natural and intermediate reservoirs 75
for SARS-CoV, respectively, and that SARS-CV transmitted from palm civets to humans 76 in an animal market in Southern China (12) (13) (14) . It has been reported that 2019-nCoV also 77 infected humans in an animal market in Wuhan, although the animal source of the 78 outbreak is currently unknown. Moreover, it has been confirmed that 2019-nCoV has the 79 capacity to transmit from human to human. 80
Coronaviruses are a large family of single-stranded enveloped RNA viruses and 81 can be divided into four major genera (15) . Both SARS-CoV and 2019-nCoV belong to 82 the -genus. An envelope-anchored spike protein mediates coronavirus entry into host 83 cells by first binding to a host receptor and then fusing viral and host membranes (16) . A 84 defined receptor-binding domain (RBD) of SARS-CoV spike specifically recognizes its 85 on February 13, 2020 by guest http://jvi.asm.org/ Downloaded from host receptor angiotensin-converting enzyme 2 (ACE2) (17, 18) . Different lines of 86 research have shown that which host is susceptible to SARS-CoV infection is primarily 87 determined by the affinity between the viral RBD and host ACE2 in the initial viral 88 attachment step (19) (20) (21) (22) (23) . In a span of about 10 years, we determined a series of crystal 89 structures of SARS-CoV RBD complexed with ACE2; the RBDs were from SARS-CoV 90 strains isolated from different hosts species in different years and the ACE2 receptor 91 orthologues were derived from different animal species (18, (24) (25) (26) . These structures 92 showed that SARS-CoV RBD contains a core structure and a receptor-binding motif 93 (RBM), and that the RBM binds to the outer surface of the claw-like structure of ACE2 94 ( Fig. 1A ) (25). Importantly, we identified two virus-binding hotspots on human ACE2 95 (24, 26) . A number of naturally selected RBM mutations occurred near these two virus-96 binding hotspot and these residues largely determined the host range of SARS-CoV ( Fig.  97 1B, 1C). Furthermore, we discovered specific amino acids at 442, 472, 479, 480 and 487 98 positions that enhance viral binding to human ACE2, and some other amino acids at these 99 same positions that enhance viral binding to civet ACE2 (Fig. 1C ). Importantly, when all 100 human-ACE2-favoring residues were combined into one RBD, this RBD binds to human 101 ACE2 with super affinity and the corresponding spike protein mediates viral entry into 102 human cells with super efficiency (Fig. 1C ) (26). An RBD with super affinity for civet 103 ACE2 was also designed and empirically confirmed ( Fig. 1C ) (26). These gain-of-104 function data provided strong supporting evidence for the accuracy of our structural 105 predictions. A long-term goal of these earlier studies is to establish a structure-function 106 predictive framework for improved epidemic surveillance. More specifically, we aim to 107 The 2019-nCoV spike phylogeny is firmly rooted among other -genus lineage b 116 bat SARS-like coronaviruses (Fig. 2 ), but is ancestral to both human SARS-CoV 117 (epidemic strain isolated in year 2002) and bat SARS-CoV strains that use ACE2 118 receptor to enter and infect primary host lung cells (11, 17) . The overall sequence 119 similarities between 2019-nCoV spike and SARS-CoV spike (isolated from human, civet 120 or bat) are around 76%-78% for the whole protein, around 73%-76% for the RBD, and 121 50%-53% for the RBM (Fig. 3A, 3B ). In comparison, human coronavirus MERS 122 coronavirus (MERS-CoV) and bat MERS-like coronavirus HKU4 share lower sequence 123 similarities in their spikes, RBDs or RBM (Fig. 3C) , and yet they recognize the same 124 receptor dipeptidyl peptidase 4 (DPP4) (27, 28) . Thus, sequence similarities between 125 2019-nCoV and SARS-CoV spikes suggest the possibility for them to share the same 126 receptor ACE2. Importantly, compared to SARS-CoV RBM, 2019-nCoV RBM does not 127 contain any deletion or insertion (except for a one-residue insertion on a loop away from 128 the ACE2-binding region) ( Fig. 3A) , providing additional evidence that 2019-nCoV uses 129 ACE2 as its receptor. Furthermore, among the 14 ACE2-contacting residues in the RBD, as the receptor for 2019-nCoV surrounds the five residues in 2019-nCoV RBM that 133 underwent natural selections in SARS-CoV and played critical roles in the cross-species 134 transmission of residue 442, 472, 479, 480, 487 in SARS-CoV RBD) 135 ( Fig. 1B) . We discuss these residues in more details below. 136
First, residue 493 in 2019-nCoV RBD (corresponding to residue 479 in SARS-137
CoV) is a glutamine (Fig. 1B, 1D ). A previously designed SARS-CoV RBD is optimal 138 for binding to human ACE2 (Fig. 1B, 1C ) (26). Residue 479 in SARS-CoV RBD is 139 located near virus-binding hotspot Lys31 (i.e., hotspot-31) on human ACE2 (Fig. 1C) . CoV) is an asparagine (Fig. 1B, 1D ). Based on our previous structural analysis, residue 151 487 in SARS-CoV is located near virus-binding hotspot Lys353 (i.e., hotspot-353) on 152 human ACE2 ( respectively) ( Fig. 1B, 1C, 1D ). Based on our previous structural analysis, these three 169 residues in SARS-CoV RBD play significant roles, albeit not as dramatic as residues 479 170 and 487, in ACE2 binding (24-26). More specifically, Tyr442 of human and civet SARS- Lys353 and no longer needs strong support from neighboring residues. A previously 191 designed SARS-CoV RBD is optimal for binding to civet ACE2 (Fig. 1B, 4B ) (26). In 192 this designed RBD, Tyr442 forms a hydrogen bond with Thr31 of civet ACE2, and 193 Arg479 forms a strong bifurcated salt bridge with Glu35 of civet ACE2. Moreover, in the 194 designed RBD, Pro472 avoids unfavorable interactions with Thr82 of civet ACE2, and 195 Gly480 does not provide unneeded support for hotspot-353. Furthermore, in the designed 196 RBD, Thr487 provides limited but helpful support for hotspot-353. Here we constructed a 197 structural model for the complex of 2019-nCoV RBD and civet ACE2 (Fig. 4C) ACE2. Thus, 2019-nCoV likely still uses civet ACE2 as its receptor, although it appears 202 that 2019-nCoV RBD has not evolved adaptively for civet ACE2 binding. Moreover, 203 2019-nCoV likely does not use mouse or rat ACE2 as its receptor because mouse or rat 204 ACE2 contains a histidine at the 353 position, which does not fit into the virus/receptor 205 interact as well as a lysine does (Fig. 3A) . 2019-nCoV RBD likely recognizes ACE2 206 from pigs, ferrets, cats, orangutans, monkeys and humans with similar efficiency, because 207 these ACE2 molecules are identical or similar in the critical virus-binding residues. The 208 situation involving bat ACE2 is complex because of the diversity of bat species (29). most likely has originated from bats, given its close phylogenetic relationship with other 234 -genus lineage b bat SARS-CoV (Fig. 2) . Moreover, 2019-nCoV likely recognizes 235 ACE2 from a diversity of animal species, including palm civets, as its receptor. In the 236 case of SARS-CoV, some of its critical RBM residues were adapted to human ACE2, 237 while some others were adapted to civet ACE2 (26) ; this type of partial viral adaptations 238 to two host species promoted virus replication and cross-species transmission between 239 the two host species. In the case of 2019-nCoV, however, there is no strong evidence for 240 adaptive mutations in its critical RBM residues that specifically promote viral binding to 241 civet ACE2. Hence, either palm civets were not intermediate hosts for 2019-nCoV, or 242 they passed 2019-nCoV to humans quickly before 2019-nCoV had any chance to adapt to 243 civet ACE2. Like SARS-CoV, 2019-nCoV will likely replicate inefficiently in mice and 244 rats, ruling them out as intermediate hosts for 2019-nCoV. Moreover, we predict that 245 either 2019-nCoV or laboratory mice and rats would need to be genetically engineered 246 on February 13, 2020 by guest http://jvi.asm.org/ Downloaded from before a robust mouse or rat model for 2019-nCoV would become available. Pigs, ferrets, 247 cats and non-human primates contain largely favorable 2019-nCoV-contacting residues 248 in their ACE2, and hence may serve as animal models or intermediate hosts for 2019-249 nCoV. It is worth noting that SARS-CoV was isolated in wild palm civets near Wuhan in 250 2005 (9), and its RBD had already been well adapted to civet ACE2 (except for residue 251 487). Thus, bats and other wild animals in and near Wuhan should be screened for both 252 -CoV and 2019-nCoV. 253 These above analyses are based on the modeling of 2019-nCoV RBD/ACE2 254 interactions, heavily grounded in a series of atomic level structures of SARS-CoV 255 isolated from different hosts in different years (18, (24) (25) (26) . There are certainly other 256 factors that affect the infectivity and pathogenesis of 2019-nCoV and will need to be 257 investigated. Nevertheless, our decade-long structural studies on SARS-CoV have firmly 258 shown that receptor recognition by SARS-CoV is one of the most important determinants 259 of its cross-species transmission and human-to-human transmission, a conclusion that has 260 been confirmed by different lines of research (13, 14) . One of the long-term goals of our 261 previous structural studies on SARS-CoV was to build an atomic-level iterative 262 framework of virus-receptor interactions that facilitate epidemic surveillance, predict 263 species-specific receptor usage, and identify potential animal hosts and likely animal 264 models of human diseases. This study provides a robust test of this reiterative framework, 265 providing the basic, translational and public health research communities with predictive 266 insights that may help study and battle this novel 2019-nCoV. 267
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Materials and Methods 269
Structural analysis. Software Coot was used for introducing mutations to structural 270 models (32). Software PyMol was used for preparing structural figures (33) . For viral adaption to ACE2, > means "is more adapted" and = means "is similarly Spike protein sequences of selected -genus lineage b coronaviruses were aligned and 454 phylogenetically compared. Sequences were aligned using free end gaps with the 455 Blosum62 cost matrix in Geneious Prime. The tree was constructed using the neighbor-456 joining method based on the multiple sequence alignment, also in Geneious Prime. 457
Numbers following the underscores in each sequence correspond to the GenBank 458 accession number. The radial phylogram was exported from Geneious and then rendered 459 for publication using EvolView (evolgenius.info) and Adobe Illustrator CC 2020. 
